Clinical Trials Browser

Completed × INDUSTRY × milademetan × Clear all

NCT01877382 2025-03-27

A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas

Phase 1 Completed

107 enrolled 29 charts

Lymphoma

NCT03671564 2023-11-07

Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 1 Completed

14 enrolled 14 charts

Other hematologic neoplasm

Neoplasms, Leukemia, Myeloid, Acute